Human interleukin 2: physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromes. 1983

K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann

UI MeSH Term Description Entries
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann
January 1985, Cancer investigation,
K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann
January 1981, Acta medica Scandinavica,
K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann
August 1981, Blut,
K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann
January 1992, Advances in clinical chemistry,
K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann
September 1994, Pharmacological reviews,
K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann
January 1997, Toxicology and applied pharmacology,
K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann
August 2000, The international journal of biochemistry & cell biology,
K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann
April 2022, International journal of molecular sciences,
K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann
May 2012, Circulation research,
K Welte, and S Venuta, and C Y Wang, and S P Feldman, and N Ciobanu, and G Kruger, and H J Feickert, and V J Merluzzi, and N Flomenberg, and M A Moore, and R Mertelsmann
January 1983, Journal of clinical immunology,
Copied contents to your clipboard!